Biofortified wheat
Dietary SupplementExtrinsic label 67Zn (ZnSO4) 0.2mg 70Zn added to the IV dose
Other names: Esperia
NCT Number: NCT01775319
Study part 1 and 2 Assessment of Zn absorption from regular and biofortified wheat: stable isotope absorption studies in women of childbearing age consuming test meals prepared from either the biofortified Zn wheat, regular wheat or post-harvest fortified wheat at two different extraction rates.
Study part 3 Assessment of Zn absorption from intrinsically and extrinsically labeled wheat: stable isotope absorption studies in women of childbearing age, or men, consuming test meals prepared from either intrinsically labeled Zn biofortified wheat, regular wheat or post-harvest fortified wheat extrinsically labeled immediately before consumption.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
The overall goal of study part 1 and 2 is to evaluate and compare the fractional and absolute Zn absorption from biofortified wheat cultivar (60 ppm Zn) to regular wheat (28 ppm Zn) and to post harvest fortified wheat (60 ppm Zn) for a total of 3 test meals per study. The studies will be conducted with products based on wheat with high extraction rate (study part 1) and medium extraction rate (study part 2) in two separate groups of women of childbearing age.
The goal of study part 3 is to investigate the difference of absorption measurements between intrinsically and extrinsically labeled biofortified wheat. The label of the test meals will have the same nature as the fortificant itself (extrinsic vs intrinsic), for a total of 3 test meals.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Extrinsic label 67Zn (ZnSO4) 0.2mg 70Zn added to the IV dose
Other names: Esperia
Extrinsic label 67Zn (ZnSO4) 0.2mg 70Zn added to the IV dose
Time frame: 3 months
Fractional zinc absorption (in %) will be assessed with stable isotopes of zinc using a double isotope technique.
Time frame: 3 months
Time frame: 2 months
Swiss Federal Institute of Technology
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07585318
Child Nutrition Disorders, Iron Deficiencies
Guatemala City, Departamento de Guatemala, Guatemala
View Trial DetailsNCT02233764
Iron Deficiencies, Iron Deficiency
Bengaluru, Karnataka, India
View Trial DetailsNCT05085834
Cardiovascular Diseases, Inflammation
Cleveland, Ohio, United States
View Trial DetailsNCT03283813
Body Weight, Glucose Metabolism Disorders
Novara, Italy
View Trial Details